Finance

Lists
Why is NEO up २.१२%?
Dive Deeper
NEO:NASDAQ
NeoGenomics, Inc.
US$ १६.८४
+२.१२%
(+०.३५) 1D
US$ १६.८४
०.००% (०.००)
After hours
Closed: नोभेम्बर ६, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEO...
Open
US$ १६.८५
High
US$ १६.९३
Low
US$ १६.१२
Mkt. cap
२.१८ अरब
Avg. vol.
२१.२१ लाख
Volume
१३.१४ लाख
52-wk high
US$ २०.१५
52-wk low
US$ ७.०६
EPS
-US$ ०.२५
Beta
१.८७
Shares outstanding
१२.९४ करोड
No. of employees
२ हजार
Open
US$ १६.८५
High
US$ १६.९३
Low
US$ १६.१२
Mkt. cap
२.१८ अरब
Avg. vol.
२१.२१ लाख
Volume
१३.१४ लाख
52-wk high
US$ २०.१५
52-wk low
US$ ७.०६
EPS
-US$ ०.२५
Beta
१.८७
Shares outstanding
१२.९४ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees२.५ हजार
Founded२००२
Headquartersफोर्ट मायर्स, फ्लोरिडा, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websiteneogenomics.com
Analyst ratings
Based on 9 analysts giving stock ratings to NEO in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NEO in the last 3 months.
Highest
Current US$ १६.८४
US$ ३५.०० (+१०७.८४%)
Average
US$ २४.७१ (+४६.७३%)
Lowest
US$ २०.०० (+१८.७६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lu Li
Bank of America Securities
Hold
Maintained
-
-
10/29/2026
Daniel Brennan
TD Cowen
Buy
Maintained
US$ २३.००
+३६.६%
10/29/2026
Tycho Peterson
Jefferies
Buy
Maintained
US$ २१.००
+२४.७%
10/29/2026
Michael Matson
Needham
Buy
Reiterated
US$ २२.००
+३०.६%
10/29/2026
Puneet Souda
Leerink Partners
Buy
Reiterated
US$ ३५.००
+१०७.८%
10/29/2026
David Westenberg
Piper Sandler
Buy
Reiterated
US$ २४.००
+४२.५%
10/30/2026
Michael Ryskin
Bank of America Securities
Hold
Reiterated
US$ २०.००
+१८.८%
10/06/2026
Matt Larew
William Blair
Hold
Maintained
-
-
10/06/2026
Bruce Jackson
StoneX
Buy
Maintained
US$ २०.००
+१८.८%
10/06/2026
Mark Massaro
BTIG
Buy
Upgraded
US$ २८.००
+६६.३%
10/06/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
US$ १९.००
+१२.८%
07/29/2026
William Bonello
Craig-Hallum
Buy
Maintained
US$ १९.००
+१२.८%
07/29/2026
Andrew Brackmann
William Blair
Hold
Maintained
-
-
05/27/2026
Unknown Analyst
Stephens
Buy
Maintained
US$ १५.५०
-८%
04/29/2026
Unknown Analyst
Guggenheim
Hold
Maintained
-
-
02/17/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ १५.००
-१०.९%
02/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१९.०२ करोड
१८.६७ करोड
२०.१७ करोड
२०.९३ करोड
Cost of goods sold
१०.६८ करोड
१०.५८ करोड
१०.९८ करोड
११.२७ करोड
Cost of revenue
१०.६८ करोड
१०.५८ करोड
१०.९८ करोड
११.२७ करोड
Research and development expenses
९१.७९ लाख
९५.३४ लाख
१.०८ करोड
९८.५५ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८.६६ करोड
८.८८ करोड
९.०९ करोड
९.४६ करोड
Operating expense
९.५८ करोड
९.८३ करोड
१०.१६ करोड
१०.४५ करोड
Total operating expenses
२०.२७ करोड
२०.४१ करोड
२१.१४ करोड
२१.७२ करोड
Operating income
-१.२५ करोड
-१.७४ करोड
-९७.७१ लाख
-७८.९९ लाख
Other non operating income
८४.०० हजार
-१२.०० हजार
-१७.०० हजार
-९.०० हजार
EBT including unusual items
-१.२४ करोड
-१.७६ करोड
१८.२६ लाख
-८०.२१ लाख
EBT excluding unusual items
-१.१५ करोड
-१.६८ करोड
-९३.५५ लाख
-७९.७९ लाख
Income tax expense
-२५.२५ लाख
-४.७२ लाख
-४.१२ लाख
-४.७५ लाख
Effective tax rate
२०.३५%
२.६९%
-२२.५६%
५.९२%
Other operating expenses
-
-
-
-
Net income
-९८.८१ लाख
-१.७१ करोड
२२.३८ लाख
-७५.४६ लाख
Net profit margin
-५.२०%
-९.१६%
१.११%
-३.६१%
Earnings per share
०.०६
०.०१
०.०५
०.०७
Interest and investment income
१५.२३ लाख
१२.७३ लाख
१२.१४ लाख
११.९६ लाख
Interest expense
-५.९९ लाख
-५.९८ लाख
-७.८१ लाख
-१२.६७ लाख
Net interest expenses
९.२४ लाख
६.७५ लाख
४.३३ लाख
-७१.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
३९.१३ लाख
-१०.२६ लाख
६७.६१ लाख
८६.५२ लाख
Gain or loss from assets sale
३१.०० हजार
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू